Adjuvant chemotherapy for locally advanced rectal cancer: Is it a given?

Journal of Clinical Oncology

Volumn 33, Issue 17, 2015, Pages 1878-1880

  Hong, Theodore S ^a   Ryan, David P ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; FLUOROPYRIMIDINE; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN; ANTINEOPLASTIC AGENT; PLATINUM COMPLEX;

ADJUVANT CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE FREE SURVIVAL; DISTANT METASTASIS; EMOTION; FOLLOW UP; HIGH RISK PATIENT; HUMAN; INCIDENCE; INTENTION TO TREAT ANALYSIS; LOCALLY ADVANCED RECTAL CANCER; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE CARE; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; RADIATION DOSE; RECTUM CANCER; RISK FACTOR; RISK REDUCTION; SENSORY NEUROPATHY; SOCIAL INTERACTION; TRANSRECTAL ULTRASONOGRAPHY; TREATMENT DURATION; TUMOR VOLUME; ADJUVANT CHEMORADIOTHERAPY; ADJUVANT THERAPY; CHEMICALLY INDUCED; DRUG ADMINISTRATION; DRUG EFFECTS; EUROPE; PATHOLOGY; PERIPHERAL NEUROPATHY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECTAL NEOPLASMS; SENSORY NERVE CELL; TREATMENT OUTCOME; UNITED STATES;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMORADIOTHERAPY, ADJUVANT; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; EUROPE; FLUOROURACIL; HUMANS; LEUCOVORIN; NEOADJUVANT THERAPY; NEOPLASM STAGING; ORGANOPLATINUM COMPOUNDS; PERIPHERAL NERVOUS SYSTEM DISEASES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECTAL NEOPLASMS; SENSORY RECEPTOR CELLS; TREATMENT OUTCOME; UNITED STATES;

EID: 84937113511     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2015.60.8554     Document Type: Note

References (14)

1. Folkesson J, Birgisson H, Pahlman L, et al: Swedish Rectal Cancer Trial: Long lasting benefits from radiotherapy on survival and local recurrence rate. J Clin Oncol 23:5644-5650, 2005
2. Fisher B, Wolmark N, Rockette H, et al: Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: Results from NSABP protocol R-01. J Natl Cancer Inst 80:21-29, 1988
3. Petersen SH, Harling H, Kirkeby LT, et al: Postoperative adjuvant chemotherapy in rectal cancer operated for cure. Cochrane Database Syst Rev 3:CD004078, 2012
4. [No authors listed]: Efficacy of adjuvant fluorouracil and folinic acid in colon cancer: International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators. Lancet 345:939-944, 1995
5. Sauer R, Becker H, Hohenberger W, et al: Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731-1740, 2004
6. Bosset JF, Calais G, Mineur L, et al: Fluoruracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: Long-term results of the EORTC 22921 randomised study. Lancet Oncol 15:184-190, 2014
7. Collette L, Bosset JF, den Dulk M, et al: Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: Does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organisation for Research and Treatment of Cancer Radiation Oncology Group. J Clin Oncol 25:4379-4386, 2007
8. Glynne-Jones R, Counsell N, Quirke P, et al: Chronicle: Results of a randomised phase III trial in locally advanced rectal cancer after neoadjuvant chemoradiation randomising postoperative adjuvant capecitibine plus oxaliplatin (XELOX) versus control. Ann Oncol 25:1356-1362, 2014
9. Cionini L, Sainato A, De Paoli A, et al: Final results of randomized trial on adjuvant chemotherapy after preoperative chemoradiation in rectal cancer. Radiother Oncol 96:S113-S114, 2010 (suppl 1)
10. Breugom AJ, van Gijn W, Muller EW, et al: Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo) radiotherapy and total mesorectal excision: A Dutch Colorectal Cancer Group (DCCG) randomized phase III trial. Ann Oncol 26:696-701, 2015
11. Hong YS, Nam BH, Kim KP, et al: Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): An open-label, multicentre, phase 2, randomised controlled trial. Lancet Oncol 15:1245-1253, 2014
12. André T, Boni C, Navarro M, et al: Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol 27:3109-3116, 2009
13. Mols F, Beijers T, Lemmens V, et al: Chemotherapy-induced neuropathy and its association with quality of life among 2- to 11-year colorectal cancer survivors: Results from the population-based PROFILES registry. J Clin Oncol 31:2699-2707, 2013
14. Schrag D, Weiser MR, Goodman KA, et al: Neoadjuvant chemotherapy without routine use of radiation therapy for patients with locally advanced rectal cancer: A pilot trial. J Clin Oncol 32:513-518, 2014